Piperacillin

CAT:
804-HY-B1923-01
Size:
50 mg

For Laboratory Research Only. Not for Clinical or Personal Use.

  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Piperacillin - image 1

Piperacillin

  • Description:

    Piperacillin is a semisynthetic broad-spectrum β-lactam antibiotic which exhibits potent bactericidal activity against Gram-negative bacteria as well as select Gram-positive strains through penicillin-binding proteins. Piperacillin is most commonly used in combination with the β-lactamase inhibitor Tazobactam[1][2][3].
  • Product Name Alternative:

    Pipracil
  • UNSPSC:

    12352005
  • Hazard Statement:

    H317, H334
  • Target:

    Antibiotic; Bacterial; Beta-lactamase; Penicillin-binding protein (PBP)
  • Type:

    Reference compound
  • Related Pathways:

    Anti-infection
  • Applications:

    COVID-19-immunoregulation
  • Field of Research:

    Infection; Cancer
  • Assay Protocol:

    https://www.medchemexpress.com/piperacillin.html
  • Concentration:

    10mM
  • Purity:

    98.37
  • Solubility:

    DMSO : 100 mg/mL (ultrasonic)
  • Smiles:

    O=C ([C@@H] (C (C) (C) S[C@]1 ([H]) [C@@H]2NC ([C@H] (NC (N3C (C (N (CC) CC3) =O) =O) =O) C4=CC=CC=C4) =O) N1C2=O) O
  • Molecular Formula:

    C23H27N5O7S
  • Molecular Weight:

    517.55
  • Precautions:

    H317, H334
  • References & Citations:

    [1]Fu KP, et al. Piperacillin, a new penicillin active against many bacteria resistant to other penicillins. Antimicrob Agents Chemother. 1978, 13 (3) :358-67. |[2]Bodey GP, et al. Piperacillin: In Vitro Evaluation. Antimicrob Agents Chemother. 1978, 14 (1) :78-87.|[3]Harada Y, et al. In vitro and in vivo activities of piperacillin-tazobactam and meropenem at different inoculum sizes of ESBL-producing Klebsiella pneumoniae. Clin Microbiol Infect. 2014, 20 (11) :O831-9.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    -20°C, 3 years; 4°C, 2 years (Powder)
  • Scientific Category:

    Reference compound1
  • Clinical Information:

    Launched
  • Isoform:

    β-lactam
  • Citation 01:

    Antimicrob Agents Chemother. 2023 Jun 15;67 (6) :e0160322.|Int J Antimicrob Agents. 2025 Jun 9:107551.|J Antimicrob Chemother. 2025 Nov 5:dkaf408.|medRxiv. 2025 Mar 13:2025.03.11.25323422.|Microbiol Spectr. 2023 Feb 14;11 (1) :e0303822.|Microbiol Spectr. 2023 Jun 15;11 (3) :e0069223.|Molecules. 2025 Mar 9;30 (6) :1224.|PLoS Pathog. 2024 Dec 31;20 (12) :e1012783.|Biomed Res Int. 2018 Jul 2:2018:3579832.|bioRxiv. 2024 May 10.|Nat Commun. 2022 Mar 2;13 (1) :1116.
  • CAS Number:

    61477-96-1